STUDI IN SILICO SENYAWA YANG TERKANDUNG DI DALAM RIMPANG TEMULAWAK (Curcuma xanthorriza Roxb.) SEBAGAI ANTIHEPATITIS B

Authors

  • Riska Prasetiawati Program Studi Farmasi, Fakultas Matematika dan Ilmu Pengetahuan Alam, Universitas Garut
  • Shielva Meilanda Program Studi Farmasi, Fakultas Matematika dan Ilmu Pengetahuan Alam, Universitas Garut
  • Benny Permana Sekolah Farmasi, Institut Teknologi Bandung
  • Novriyanti Lubis Program Studi Farmasi, Fakultas Matematika dan Ilmu Pengetahuan Alam, Universitas Garut

DOI:

https://doi.org/10.36387/jifi.v4i2.788

Keywords:

Curcuma Rhizome, molecular docking, HBV receptor, DNA virus, reverse transcription, Curcuma Rhizome, Molecular Docking, HBV Receptor, DNA Virus, Reverse Transcription

Abstract

Hepatitis B is inflammation of the liver caused by the Hepatitis B virus (HBV). HBV is a DNA virus that plays a role in virus replication through the process of reverse transcription.  The curcuma rhizome against HBV reseptor with protein ID 1A7L and ID 1IUD using the Autodock Tools program. The 1A7L receptor showed that the curcumin compound had ?G of -8.05 kcal/mol and the value of inhibition constant (KI) of 1.26 µM, natural ligands had ?G of -8.17 kcal/mol and the value of KI was 1.03 µM, and Lamivudin as a comparative ligand had ?G of -7.02 kcal/mol and the value of the KI was 7.13 µM, while the result of the 1IUD receptor had ?G of -8.44 kcal/mol and KI value of 647.75 nM, natural ligand had ?G of -6.90 kcal/mol and KI value of 8.78 µM, and Lamivudin as a comparative ligand had ?G of -5.01 kcal/mol and the value of the KI was 211.47 nM. The absorption and distribution prediction results showed the curcumin compound had a Caco2 value of 20.07 nm sec-1, the percentage of HIA was 94.40% and plasma Binding Protein was 88.03%. The curcumin compound  fulfills all Lipinski's  is non-mutagenic and carcinogenic negative. 

References

Fajar Z, Hasta mulyani sri, Marselina E. pemodelan deteksi penyakit sirosis hati dengan menggunakan jaringan syaraf tiruan. 2012. Published online 2012.

Firdayani ., Kusumaningrum S, Miranti YR. Potensi Senyawa Bioaktif Tanaman genus phyllanthus sebagai Inhibitor Replikasi virus hepatitis b. J Bioteknol Biosains Indones. 2017;4(2).

Marinda FD. Hepatoprotective effect of curcumin in chronic hepatitis. J Major. 2014;3(7).

Ab Halim MR. Validation of Gc-Ms Method for Standardization of Curcuma Xanthorrhiza Extracts Using Biochemical Markers , Ar-Curcumene and Xanthorrhizol. Published online 2014:1-24.

Lin J, Lin-Shiau S. Mechanisms of cancer chemoprevention by curcumin. Proc Natl Sci Counc Repub China B. 2001;25(2):59-66.

Lipinski CA, Lombardo F, Dominy BW, Feeney PJ. Experimental and computational approaches to estimate solubility and permeability in drug discovery and development settings. Adv Drug Deliv Rev. 2012;64

Agustina W, Susanti E, Yunita N, Yamtinah S. Modul Chem Office (Chem Draw 3D). Published online 2018:1-22.

WHO. Hepatitis B WHO | Hepatitis B. WHO Fact sheet. 2015;(204 http://www.who.int/mediacentre/factsheets/fs204/en/).

Gani R a. Pengobatan Terkini Hepatitis Kronik B dan C. Perhimpun Rumah Sakit Seluruh Indones. 2005;(1):1-6.

Candra AA. Aktivitas Hepatoprotektor Temulawak pada Ayam yang Diinduksi Pemberian Parasetamol. J Penelit Pertan Terap. 2013;13(2).

Published

2021-12-29

How to Cite

1.
STUDI IN SILICO SENYAWA YANG TERKANDUNG DI DALAM RIMPANG TEMULAWAK (Curcuma xanthorriza Roxb.) SEBAGAI ANTIHEPATITIS B. JIFI [Internet]. 2021 Dec. 29 [cited 2026 Apr. 19];4(2):245-5. Available from: https://e-jurnal.stikes-isfi.ac.id/index.php/JIFI/article/view/788